IL-2 activated cell-mediated immunotherapy: Control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2

S. Slavin, A. Ackerstein, E. Kedar, L. Weiss

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'IL-2 activated cell-mediated immunotherapy: Control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2'. Together they form a unique fingerprint.

Immunology and Microbiology

Veterinary Science and Veterinary Medicine

Medicine and Dentistry

Keyphrases